相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
Susanne Tan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease
Marianthi Papagianni et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2014)
Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
Justyna Kuliczkowska Plaksej et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome
Carley A. Gomez-Meade et al.
WORLD JOURNAL OF DIABETES (2013)
The diagnosis of non-alcoholic fatty liver disease
N. Wlazlo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Metformin and its clinical use: new insights for an old drug in clinical practice
Arrigo F. G. Cicero et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Konstantinos Tziomalos et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Dimitrios Panidis et al.
HUMAN REPRODUCTION (2012)
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Helen Jones et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome
Maria F. Gangale et al.
CLINICAL ENDOCRINOLOGY (2011)
Fatty liver index in polycystic ovary syndrome
Elisabeth Lerchbaum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
The Lipid Accumulation Product Is Associated with Impaired Glucose Tolerance in PCOS Women
Elisabeth Wehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Mark O. Goodarzi et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
A simple index of lipid overaccumulation is a good marker of liver steatosis
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2010)
Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome
Athina Markouo et al.
FERTILITY AND STERILITY (2010)
Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?
Robert P. Kauffman et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Noninvasive Assessment of Liver Disease Severity With Liver Fat Score and CK-18 In NAFLD: Prognostic Value of Liver Fat Equation Goes Beyond Hepatic Fat Estimation
Giovanni Musso et al.
HEPATOLOGY (2010)
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
E. Vassilatou et al.
HUMAN REPRODUCTION (2010)
Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome
Susanne Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Lipid Accumulation Product and All-cause Mortality in Patients at High Cardiovascular Risk: A PreCIS Database Study
Adriana G. Ioachimescu et al.
OBESITY (2010)
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Abigail Fraser et al.
DIABETES CARE (2009)
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen et al.
GASTROENTEROLOGY (2009)
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls
Frangiskos Economou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
A. J. Goverde et al.
HUMAN REPRODUCTION (2009)
Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome
D. Wiltgen et al.
HUMAN REPRODUCTION (2009)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome
G. Targher et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Srinivasan Dasarathy et al.
JOURNAL OF HEPATOLOGY (2009)
The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome
D. Preiss et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National heart, lung, and blood institute sponsored women's ischemia syndrome evaluation
Leslee J. Shaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies
Robert P. Myers et al.
LIVER INTERNATIONAL (2008)
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients
Giovanni Targher et al.
DIABETES CARE (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Practices of liver biopsy in France: Results of a prospective nationwide survey
JF Cadranel et al.
HEPATOLOGY (2000)
分享论文
